Cargando…

Altered VWF:ADAMTS13 homeostasis is a target for therapeutic intervention in sickle cell disease

Detalles Bibliográficos
Autores principales:	Chaturvedi, Shruti, DeBaun, Michael R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546592/ https://www.ncbi.nlm.nih.gov/pubmed/36170252 http://dx.doi.org/10.1073/pnas.2213079119

Ejemplares similares

Subsequent Response of VWF and ADAMTS13 to Aortic Valve Replacement
por: Kokame, Koichi
Publicado: (2016)

Domain-specific mechanical modulation of VWF–ADAMTS13 interaction
por: Li, Zhenhai, et al.
Publicado: (2019)

VWF–ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxycarbamide vs blood transfusion
por: Fogarty, Helen, et al.
Publicado: (2023)

The ADAMTS13–VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension
por: Newnham, Michael, et al.
Publicado: (2019)

ADAMTS13 regulation of VWF multimer distribution in severe COVID‐19
por: Ward, Soracha E., et al.
Publicado: (2021)

Role of ADAMTS13, VWF and F8 genes in deep vein thrombosis
por: Pagliari, Maria Teresa, et al.
Publicado: (2021)

Association between ADAMTS13 activity–VWF antigen imbalance and the therapeutic effect of HAIC in patients with hepatocellular carcinoma
por: Takaya, Hiroaki, et al.
Publicado: (2020)

VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma
por: Takaya, Hiroaki, et al.
Publicado: (2019)

ADAMTS13, VWF, and Endotoxin Are Interrelated and Associated with the Severity of Liver Cirrhosis via Hypercoagulability
por: Takaya, Hiroaki, et al.
Publicado: (2022)

Disappearing acts of ADAMTS13
por: Voorberg, Jan, et al.
Publicado: (2015)

Impaired exercise capacity in post–COVID-19 syndrome: the role of VWF-ADAMTS13 axis
por: Prasannan, Nithya, et al.
Publicado: (2022)

Genetic Variation in ADAMTS13 is Related to VWF Levels, Atrial Fibrillation and Cerebral Ischemic Events
por: Warlo, Ellen M. K., et al.
Publicado: (2022)

VWF/ADAMTS13 Imbalance, But Not Global Coagulation or Fibrinolysis, Is Associated With Outcome and Bleeding in Acute Liver Failure
por: Driever, Ellen G., et al.
Publicado: (2021)

Sustained VWF‐ADAMTS‐13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction
por: Fogarty, Helen, et al.
Publicado: (2022)

Low ADAMTS-13/VWF ratio and altered gut–liver axis predict complications of advanced chronic liver disease: a pilot study
por: Ponziani, Francesca Romana, et al.
Publicado: (2022)

VWF/ADAMTS13 Ratios Are Potential Markers of Immunothrombotic Complications in Patients with COVID-19: A Cross-Sectional Study
por: Madeeva, Daria V, et al.
Publicado: (2020)

The Impact of Age and BMI on the VWF/ADAMTS13 Axis and Simultaneous Thrombin and Plasmin Generation in Hospitalized COVID-19 Patients
por: Thangaraju, Kiruphagaran, et al.
Publicado: (2022)

Can ADAMTS13 Lead Us to the Paradise of Personalized Medicine?
por: Rossing, Peter, et al.
Publicado: (2013)

Detection of Plasma Protease Activity Using Microsphere-Cytometry Assays with E. coli Derived Substrates: VWF Proteolysis by ADAMTS13
por: Gogia, Shobhit, et al.
Publicado: (2015)

vWF/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease
por: Warlo, Ellen M. K., et al.
Publicado: (2017)

Effects of anti‐β2GPI antibodies on VWF release from human umbilical vein endothelial cells and ADAMTS13 activity
por: Ng, Christopher J., et al.
Publicado: (2018)

Sexual violence as a precipitator of chronic pain in young adults with sickle cell disease
por: Chopra, Maya, et al.
Publicado: (2022)

Shedding Light on the Possible Link between ADAMTS13 and Vaccine—Induced Thrombotic Thrombocytopenia
por: Szóstek-Mioduchowska, Anna, et al.
Publicado: (2021)

Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance
por: Philippe, Aurélien, et al.
Publicado: (2021)

Distinguishing Alzheimer’s Disease Patients and Biochemical Phenotype Analysis Using a Novel Serum Profiling Platform: Potential Involvement of the VWF/ADAMTS13 Axis
por: Hanas, Jay S., et al.
Publicado: (2021)

Patient-Centered eHealth Interventions for Children, Adolescents, and Adults With Sickle Cell Disease: Systematic Review
por: Badawy, Sherif M, et al.
Publicado: (2018)

Vaso-Occlusive Pain and Menstruation in Sickle Cell Disease: A Focus Group Analysis
por: Day, Melissa, et al.
Publicado: (2020)

PRO-THROMBOTIC SIGNATURE FROM NEUTROPHIL ACTIVATION AND DECREASED ADAMTS13 TO VWF RATIO IS A KEY DRIVER OF CARDIAC INJURY IN HOSPITALIZED PATIENTS WITH COVID-19
por: Wang, Stephen Yishu, et al.
Publicado: (2021)

Early lyophilized cryoprecipitate enhances the ADAMTS13/VWF ratio to reduce systemic endotheliopathy and lessen lung injury in a mouse multiple-trauma hemorrhage model
por: Zeineddin, Ahmad, et al.
Publicado: (2023)

Academic Medicine’s Journey Toward Racial Equity Must Be Grounded in History: Recommendations for Becoming an Antiracist Academic Medical Center
por: Wilkins, Consuelo H., et al.
Publicado: (2021)

Improved Guideline Adherence With Integrated Sickle Cell Disease and Asthma Care
por: McClain, Brandi L., et al.
Publicado: (2016)

ADAMTS13: An Emerging Target in Stroke Therapy
por: Chen, Xin, et al.
Publicado: (2019)

Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease
por: Rossato, Paolo, et al.
Publicado: (2022)

Enhanced VWF clearance in low VWF pathogenesis: limitations of the VWFpp/VWF:Ag ratio and clinical significance
por: Doherty, Dearbhla, et al.
Publicado: (2022)

2484: Establishment of the Tennessee-sickle cell disease network as a mechanism for engaging a rare disease population in patient centered outcomes research
por: Mayo-Gamble, Tilicia, et al.
Publicado: (2018)

The missing middle of sickle therapeutics: Multi‐agent therapy, targeting risk, using biomarkers
por: Hebbel, Robert P., et al.
Publicado: (2018)

ADAMTS2 and ADAMTS14 can substitute for ADAMTS3 in adults for pro-VEGFC activation and lymphatic homeostasis
por: Dupont, Laura, et al.
Publicado: (2022)

ADAMTS13 and Non-ADAMTS13 Biomarkers in Immune-Mediated Thrombotic Thrombocytopenic Purpura
por: Bonnez, Quintijn, et al.
Publicado: (2023)

Annual decline in lung function in adults with sickle cell disease is similar to that observed in adults with cystic fibrosis
por: Hodges, Brock, et al.
Publicado: (2022)

ADAMTS13, TTP and Beyond
por: Zheng, X Long
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_e8dti41n06ofpg6epbl949paob